IMPROVEST DIN 02369532
Status: Marketed
Holder: ZOETIS CANADA INC
Health Canada record
| Active ingredient(s) | GONADOTROPIN-RELEASING FACTOR ANALOG-DIPHTHERIA TOXOID CONJUGATE 0.2 MG |
|---|---|
| Dosage form | Solution |
| Route | Subcutaneous |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 03-Oct-2011 |
| Current status date | 23-Sep-2016 |
| Source | Health Canada DPD |
Establishment licence of the holder
Zoetis Canada Inc — licence 102076, currently licensed, last inspection rating C (2023-10-05).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 27814 | 2022-03-24 | Supplement to a New Drug Submission (SNDS) | CHANGE TO DOSAGE INFORMATION AND WARNINGS |
| 18377 | 2016-08-18 | Supplement to a New Drug Submission (SNDS) | ADDITIONAL INDICATION |
| 17430 | 2015-11-02 | Supplement to a New Drug Submission (SNDS) | FORMULATION CHANGE |
| 15134 | 2014-01-20 | New Drug Submission (NDS) | TRANSFER OF DRUG IDENTIFICATION NUMBER (DIN) HOLDER |
| 13150 | 2012-03-23 | Supplement to a New Drug Submission (SNDS) | Alternate dosing schedule |
| 12451 | 2011-06-22 | New Drug Submission (NDS) |